Eisai
4523.T
#1956
Rank
C$11.99 B
Marketcap
$42.55
Share price
2.83%
Change (1 day)
-31.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.12. In 2022 the company made an earnings per share (EPS) of $2.29 a decrease over its 2021 EPS that were of $10.18.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9528.6%
2022$2.29-77.48%
2021$10.18-41.88%
2020$17.51-0.94%
2019$17.6852.59%
2018$11.59124.17%
2017$5.17-49.42%
2016$10.2237.08%
2015$7.45-11.75%
2014$8.45-3.23%
2013$8.73-18.56%
2012$10.72-15.51%
2011$12.69-3.75%
2010$13.18-1.36%
2009$13.36